BEHAVIORAL-EFFECTS OF SELECTIVE DOPAMINE-D-1 AND DOPAMINE-D-2 AGONISTS AND ANTAGONISTS IN GUINEA-PIGS

被引:17
作者
BRENT, PJ
机构
[1] Neuropharmacology Laboratory, Faculty of Medicine, University of Newcastle, 2308, NSW
关键词
D-1 AGONIST ANTAGONIST; D-2 AGONIST ANTAGONIST; QUINPIROLE; SKF; 38393; SCH; 23390; SULPIRIDE; RACLOPRIDE; LOCOMOTOR ACTIVITY; GUINEA-PIG;
D O I
10.1007/BF02244179
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
This study describes specific behaviours in guinea-pigs after dopamine D-1 and D-2 receptor activation which differed to those described in other rodent species. Intraperitoneal (IP) administration of the dopamine D-2 receptor agonist quinpirole (1.5, 3 and 6 mg/kg) to guinea-pigs dose-dependently initiated locomotor activity and other behaviours including rearing, head-down sniffing, chewing, circling, licking and head/body shaking. Locomotor activity induced by quinpirole (3 mg/kg) was reduced by the D-2 receptor antagonists sulpiride, (100 mg/kg IP) and raclopride (10 mg/kg IP). The dopamine D-1 receptor agonist SKF 38393 (8, 16 and 32 mg/kg IP) produced little or no behavioural effect, nor did the D-1 receptor antagonist SCH 23390 (0.2 and 0.4 mg/kg IP). A 16 mg/kg dose of SKF 38393, given in combination with 3 mg/kg quinpirole, produced responses similar to quinpirole alone, whereas 32 mg/kg SKF 38393 combined with quinpirole induced vacuous oral chewing, with attenuation of locomotor activity and circling, but not other behaviours produced by this dose of quinpirole. In contrast to previous studies in rats, the responses to quinpirole (3 mg/kg) were not significantly affected by SCH 23390 (0.2 and 0.4 mg/kg). It is concluded that the guinea-pig may be a useful and interesting species for study of the behavioural effects of D-1 and D-2 agonists and antagonists, as its responses appear to differ from those of other rodent species, but are similar to some responses to D-1 agonists observed in primates.
引用
收藏
页码:201 / 207
页数:7
相关论文
共 40 条
[1]   THIENOPYRIDINE DERIVATIVES IDENTIFIED AS THE 1ST SELECTIVE, FULL EFFICACY, DOPAMINE D1 RECEPTOR AGONISTS [J].
ANDERSEN, PH ;
NIELSEN, EB ;
SCHEELKRUGER, J ;
JANSEN, JA ;
HOHLWEG, R .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1987, 137 (2-3) :291-292
[2]   DOPAMINE D-1 RECEPTOR AGONISTS COMBINED WITH THE SELECTIVE D-2 AGONIST QUINPIROLE FACILITATE THE EXPRESSION OF ORAL STEREOTYPED BEHAVIOR IN RATS [J].
ARNT, J ;
HYTTEL, J ;
PERREGAARD, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1987, 133 (02) :137-145
[4]   DOPAMINERGIC MECHANISMS IN HEMIPARKINSONIAN MONKEYS [J].
BARONE, P ;
BANKIEWICZ, KS ;
CORSINI, GU ;
KOPIN, IJ ;
CHASE, TN .
NEUROLOGY, 1987, 37 (10) :1592-1595
[5]   DIFFERENTIAL-EFFECTS OF D1 AND D2 AGONISTS IN MPTP-TREATED PRIMATES - FUNCTIONAL IMPLICATIONS FOR PARKINSONS-DISEASE [J].
BOYCE, S ;
RUPNIAK, NMJ ;
STEVENTON, MJ ;
IVERSEN, SD .
NEUROLOGY, 1990, 40 (06) :927-933
[6]   SELECTIVE D-1 DOPAMINE RECEPTOR AGONIST TREATMENT OF PARKINSONS-DISEASE [J].
BRAUN, A ;
FABBRINI, G ;
MOURADIAN, MM ;
SERRATI, C ;
BARONE, P ;
CHASE, TN .
JOURNAL OF NEURAL TRANSMISSION, 1987, 68 (1-2) :41-50
[7]   OBLIGATORY D-1 D-2 RECEPTOR INTERACTION IN THE GENERATION OF DOPAMINE AGONIST RELATED BEHAVIORS [J].
BRAUN, AR ;
CHASE, TN .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 131 (2-3) :301-306
[8]   SCH-23390 ANTAGONISM OF A D-2 DOPAMINE AGONIST DEPENDS UPON CATECHOLAMINERGIC NEURONS [J].
BREESE, GR ;
MUELLER, RA .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 113 (01) :109-114
[9]   PLASMA-CATECHOLAMINE CONCENTRATIONS DURING MORPHINE WITHDRAWAL IN CONSCIOUS GUINEA-PIGS [J].
BRENT, PJ ;
JOHNSTON, PA ;
CHAHL, LA .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1987, 14 (08) :623-631
[10]   INCREASED PLASMA-CATECHOLAMINES AND LOCOMOTOR-ACTIVITY INDUCED BY CENTRALLY ADMINISTERED SUBSTANCE-P IN GUINEA-PIGS [J].
BRENT, PJ ;
JOHNSTON, PA ;
CHAHL, LA .
NEUROPHARMACOLOGY, 1988, 27 (07) :743-748